{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-095883","form_type":"8-K","ticker":"LSH","cik":"0001996192","company_name":"Lakeside Holding Ltd","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.534924+00:00","generated_at":"2026-05-30T03:03:50.755278+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lakeside subsidiary to acquire 100% of Hupan Pharmaceutical for RMB4M (US$0.6M)","bullets":["Lakeside's subsidiary Sichuan Hupan signs deal to acquire 100% of Hupan Pharmaceutical for RMB4.0M (US$0.6M).","Payment in three installments: 20% prepayment (RMB800K) within 7 days post-signing, 60% after conditions, 20% on completion.","Sellers Hubei Haoyaoshi (90%) and Hubei Huayao (10%) transfer all equity; no third-party interests.","Target provides pharmaceutical distribution, supply chain, brand promotion, and healthcare technology support."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-095883","json":"https://secwatch.observer/filing/0001213900-24-095883.json","markdown":"https://secwatch.observer/filing/0001213900-24-095883.md","text":"https://secwatch.observer/filing/0001213900-24-095883.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1996192/000121390024095883/0001213900-24-095883-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1996192/000121390024095883/ea0220168-8k_lakeside.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:03:50.755278+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}